UT-MD Anderson Cancer Center: Hormone Therapy Could Lower Risk Of Immunotherapy-Associated Myocarditis In Women
November 03, 2022
November 03, 2022
HOUSTON, Texas, Nov. 3 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Nov. 2, 2022:
* * *
Study uncovers reason for sex differences and identifies specific targets for improving treatment efficacy
* * *
A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center and the University of California San Francisco (UCSF) has discovered the underlying cause of . . .
* * *
Study uncovers reason for sex differences and identifies specific targets for improving treatment efficacy
* * *
A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center and the University of California San Francisco (UCSF) has discovered the underlying cause of . . .